U.S. Supreme Court Says “Natural” Human Genes May Not Be Patented
The decision should reduce uncertainty in the field of molecular diagnostics.
Contributors
Susan Young
Follow @twitterapiBiomedicine Editor
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Topics
Type
Marketing to the Big Data Inside Us
In your DNA are clues to your health, your ancestry, and maybe even your purchasing preferences.
Messenger RNAs Could Create a New Class of Drugs
New partnerships could help bring a novel class of biopharmaceutical to patients.
Fireflies Inspire Brighter LEDs
A modification to existing LEDs based on firefly abdomens can boost the brightness of the light source.
Pharmaceutical Firms Widen Search for Medicines
Desperate to find new drugs, some pharmaceutical firms are outsourcing nearly half of their R&D budgets.
- «
- 1
- »
